Skip to main content

Share story

AI Products

AI glasses shipments rise 263% as Meta takes 94% of display-less segment

AI glasses shipments rise 263% as Meta takes 94% of display-less segment Image: Primary
Global AI-glasses shipments increased 263% year over year in the first half of 2026, according to Counterpoint Research figures reported by 9to5Mac. Meta held 94% of the display-less segment, with its unit volume up 260%; North America represented 50% of shipments and Western Europe 28%. Glasses with optical displays grew 449%, led by Rokid with 41% and Meta with 37%. The expansion is occurring alongside scrutiny of camera-equipped products over non-consensual filming and harassment. The figures are research-firm estimates, while Apple's reported 2027 entry remains a rumor rather than an announced product.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from 9to5Mac and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...